𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Binding of adenosine deaminase to the lymphocyte surface via CD26

✍ Scribed by Ingrid De Meester; Guido Vanham; Luc Kestens; Greet Vanhoof; Eugène Bosmans; Paul Gigase; Simon Scharpé

Publisher
John Wiley and Sons
Year
1994
Tongue
English
Weight
586 KB
Volume
24
Category
Article
ISSN
0014-2980

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Regulatory role of adenosine deaminase c
Regulatory role of adenosine deaminase complexing protein (dipeptidyl peptidase IV = CD26) on the malignancy marker adenosine deaminase: Effect of membrane cholesterol and phase-transition
✍ Abraham H. Parola; Valeria R. Caiolfa; Itzhak Ben-Shooshan; Rivka Cohen-Luria 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 200 KB 👁 2 views

While adenosine deaminase (ADA) is an established malignancy marker and its clinical involvement in severe combined immunodeficiency (SCID) is understood, the biological significance of its binding to adenosine deaminase complexing protein (CP = DPPIV = CD26) remains enigmatic. The role of lipid-pro

The effect of phenformin and other adeno
The effect of phenformin and other adenosine triphosphate (ATP)-lowering agents on insulin binding to IM-9 human cultured lymphocytes
✍ Riccardo Vigneri; Betty Maddux; Ira D. Goldfine 📂 Article 📅 1984 🏛 John Wiley and Sons 🌐 English ⚖ 568 KB

In the present study, we investigated the mechanism by which the antidiabetic drug phenformin increases insulin binding to its receptors in IM-9 human cultured lymphocytes. After a 24-hr preincubation, phenformin induced a twofold increase in specific '251-insuIin binding, and removal of phenformin